Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Janine Stutterheim

Pediatric oncologist
Acute Lymphatic Leukaemia

Phone +31 88 972 95 59




I am a paediatric oncologist with focus area for Acute Lymphatic Leukaemia. I mainly work as a supervisor in various departments. I also take care of my own patients, both clinically and polyclinically. Furthermore, I conduct research within the Pieters group and the Stam group.

Knowledge & experience
Specialism / subspecialism: haemato-oncology, acute lymphatic leukaemia (ALL), infant ALL
2006-2010 PhD research Sanquin, Amsterdam
2012-2017: education paediatrician WKZ/UMCU
2018-2021: fellow in paediatric oncology Princess Maxima Centre
2021-present: paediatric oncologist, staff member hemato-oncology department

Scientific

2006 - 2010: Minimal residual disease determination in neuroblastomas (PhD), Sanquin Amsterdam
2017 - 2020: Minimal residual disease determination in rhabdomyosarcomas (Post doc), Princess Maxima Center
2019 - present: Clinical and translational research in acute lymphatic leukaemia. Principal investigator Interfant-21

My publications on pubmed.

BIG registration
49066587501

  • Therapeutische geneesmiddelmonitoring van kinaseremmers in de kinderhemato-oncologie

    • sep. 2023
    • Tirsa, de Kluis, et al
    • Nederlands Tijdschrift voor Hematologie
  • Cell-Free RNA from Plasma in Patients with Neuroblastoma: Exploring the Technical and Clinical Potential

    • mrt. 2023
    • Nathalie S.M., Lak, et al
    • Cancers
  • Targeted locus amplification to develop robust patient-specific assays for liquid biopsies in pediatric solid tumors

    • jan. 2023
    • Lieke M.J., van Zogchel, et al
    • Frontiers in Oncology
  • Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma

    • jan. 2023
    • Nathalie S M, Lak, et al
    • JCO precision oncology
  • Essential medicines for childhood cancer in Europe

    • dec. 2022
    • , et al
    • The Lancet Oncology
View all publications